Besides, in vitro and in vivo studies suggested that EMT and EMT-associated traits of HCC are inhibited by targeting SMAD2 and SMAD4 by ectopic expression of miR-125b [184]. The gene discussed is SMAD2; the disease is hepatocellular carcinoma.